Dr. Pinkerton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2955 Ivy Rd
Charlottesville, VA 22903Phone+1 434-243-4720Fax+1 434-243-4733
Education & Training
- University of Virginia Medical CenterResidency, Obstetrics and Gynecology, 1984 - 1985
- University of Virginia Medical CenterResidency, Obstetrics and Gynecology, 1981 - 1983
- Virginia Commonwealth University School of MedicineClass of 1981
Certifications & Licensure
- VA State Medical License 1983 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 5 citationsElinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.JoAnn V Pinkerton, James A Simon, Hadine Joffe, Pauline M Maki, Rossella E Nappi
JAMA. 2024-08-22 - Female Sexual Arousal Disorder: Sildenafil Cream as Potential Treatment in Development.JoAnn V Pinkerton
Obstetrics and Gynecology. 2024-08-01 - 1 citationsDesign of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopause.JoAnn V Pinkerton, James Simon, Nick Panay, Christian Seitz, Susanne Parke
Menopause. 2024-06-01
Journal Articles
- Hormone Therapy for Postmenopausal WomenJoann Pinkerton, MD, The New England Journal of Medicine
- Vaginal Estrogen: Underprescribed Treatment for an Underdiagnosed Condition of Menopausal WomenAndrew M Kaunitz, Joann V Pinkerton, Maturitas
Authored Content
- What Was New in the World of Menopause and Hot Flash Treatment at ACOG 2024?May 2024
- What Was New in the World of Menopause at ACOG 2023?May 2023
- The Challenges of Menopause and Osteoporosis at ACOG 2022May 2022
- Hormone Therapy Does Not Impact Long‐Term All‐Cause MortalitySeptember 2018
- Join now to see all
Press Mentions
- Hormone Therapy Was Villainized for Decades. Now, It’s Back, but Who Should Really Be on It?October 30th, 2024
- Hormone Therapy for Menopause Remains at Historic Lows Despite Effectiveness and Safety ProfileSeptember 23rd, 2024
- Most Women with Genitourinary Syndrome of Menopause Do Not Receive Effective TreatmentSeptember 23rd, 2024
- Join now to see all
Grant Support
- Postpartum Gonadotropin Releasing Hormone StudyNational Center For Research Resources1999–2000
- Pulsatile Administration Of GNRH In Postpartum Lactational AmenorrheaNational Center For Research Resources1997
Committees
- Member, The Treatment of Symptoms of the Menopause Task Force, The Endocrine Society 2015 - Present
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: